Wellington Management Group LLP Lowers Stake in Chemed Corporation $CHE

Wellington Management Group LLP lowered its stake in shares of Chemed Corporation (NYSE:CHE) by 10.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,014 shares of the company’s stock after selling 230 shares during the quarter. Wellington Management Group LLP’s holdings in Chemed were worth $1,239,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Neuberger Berman Group LLC raised its position in shares of Chemed by 3.9% during the 1st quarter. Neuberger Berman Group LLC now owns 521,212 shares of the company’s stock valued at $320,712,000 after buying an additional 19,650 shares in the last quarter. Boston Trust Walden Corp raised its position in shares of Chemed by 1.7% during the 1st quarter. Boston Trust Walden Corp now owns 246,351 shares of the company’s stock valued at $151,585,000 after buying an additional 4,179 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Chemed by 9.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 218,675 shares of the company’s stock valued at $134,547,000 after buying an additional 19,421 shares in the last quarter. Northern Trust Corp raised its position in shares of Chemed by 3.4% during the 1st quarter. Northern Trust Corp now owns 215,523 shares of the company’s stock valued at $132,616,000 after buying an additional 6,988 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Chemed by 131,200.8% during the 1st quarter. GAMMA Investing LLC now owns 166,752 shares of the company’s stock valued at $102,606,000 after buying an additional 166,625 shares in the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Royal Bank Of Canada decreased their target price on shares of Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a research report on Thursday, July 31st. Oppenheimer decreased their target price on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a research report on Thursday, July 31st. Bank of America decreased their target price on shares of Chemed from $708.00 to $650.00 and set a “buy” rating on the stock in a research report on Monday, June 30th. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Saturday, July 5th. Finally, Jefferies Financial Group assumed coverage on shares of Chemed in a research report on Friday, July 25th. They issued a “hold” rating and a $500.00 target price on the stock. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $579.75.

Chemed Trading Up 1.5%

CHE stock opened at $458.62 on Monday. The firm’s 50-day moving average price is $463.24 and its two-hundred day moving average price is $537.18. Chemed Corporation has a 12-month low of $408.42 and a 12-month high of $623.60. The stock has a market capitalization of $6.68 billion, a price-to-earnings ratio of 23.58, a PEG ratio of 2.52 and a beta of 0.46.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The firm had revenue of $618.80 million during the quarter, compared to analysts’ expectations of $650.60 million. During the same quarter in the previous year, the firm posted $5.47 EPS. Chemed’s revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities analysts predict that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. This is a positive change from Chemed’s previous quarterly dividend of $0.50. Chemed’s payout ratio is presently 12.34%.

Insider Transactions at Chemed

In other news, EVP Nicholas Michael Westfall sold 10,012 shares of Chemed stock in a transaction dated Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director George J. Walsh III bought 200 shares of the business’s stock in a transaction dated Monday, August 4th. The shares were bought at an average cost of $417.10 per share, for a total transaction of $83,420.00. Following the purchase, the director directly owned 3,523 shares in the company, valued at approximately $1,469,443.30. This represents a 6.02% increase in their position. The disclosure for this purchase can be found here. Insiders own 3.29% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.